| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1055/S-2004-823066 |
| P8608 | Fatcat ID | release_dv6dh5mpdnbsrccadlkd2ktqbm |
| P932 | PMC publication ID | 2780076 |
| P698 | PubMed publication ID | 20011280 |
| P5875 | ResearchGate publication ID | 40688768 |
| P2093 | author name string | Uma Mahadevan | |
| P2860 | cites work | A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators | Q28145430 |
| Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease | Q28361615 | ||
| A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). | Q28362796 | ||
| Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease | Q32059661 | ||
| Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy | Q33332618 | ||
| Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results | Q33611631 | ||
| Epidemiology and the natural course of inflammatory bowel disease | Q33661994 | ||
| Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial | Q33872486 | ||
| Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease | Q33895677 | ||
| Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis | Q33924549 | ||
| Appendectomy and protection against ulcerative colitis | Q33937912 | ||
| Impact of cessation of smoking on the course of ulcerative colitis | Q33953697 | ||
| Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
| Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis | Q34303670 | ||
| Cyclosporine in ulcerative colitis: state of the art. | Q34320512 | ||
| Frequency of glucocorticoid resistance and dependency in Crohn's disease | Q34378274 | ||
| Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial | Q34418343 | ||
| THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. | Q34478028 | ||
| Prednisolone absorption in acute colitis | Q34494641 | ||
| Cortisone in ulcerative colitis; final report on a therapeutic trial. | Q55499879 | ||
| Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium; a report on a controlled therapeutic trial. | Q55668896 | ||
| Review article: medical treatment of severe ulcerative colitis | Q57003766 | ||
| Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man | Q57265461 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease | Q59120722 | ||
| Methotrexate for the Treatment of Crohn's Disease | Q59120846 | ||
| Oral tacrolimus treatment of severe colitis in children | Q63285890 | ||
| Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis | Q63314202 | ||
| The efficacy of tobramycin in the treatment of ulcerative colitis | Q67263770 | ||
| Survival and causes of death in patients with inflammatory bowel disease: a population-based study | Q68011834 | ||
| Mucosal capillary thrombi in rectal biopsies | Q68019522 | ||
| Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study | Q68206432 | ||
| Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial | Q68539141 | ||
| 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis | Q68989554 | ||
| 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity | Q69770535 | ||
| Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties | Q69877284 | ||
| Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial | Q69908971 | ||
| Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial | Q70148700 | ||
| Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists | Q70869283 | ||
| Methotrexate in chronic active ulcerative colitis: a double-blind, randomized, Israeli multicenter trial | Q71035874 | ||
| The long-term outcome of ulcerative colitis treated with 6-mercaptopurine | Q71500638 | ||
| Treatment of ulcerative colitis with hydrocortisone enemas. Comparison of absorption and clinical response with hydrocortisone alcohol and hydrocortisone acetate | Q71665469 | ||
| Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease | Q71991186 | ||
| Course of ulcerative colitis: analysis of changes in disease activity over years | Q72036054 | ||
| Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy | Q72130999 | ||
| Complications of corticosteroid therapy | Q72174881 | ||
| Exacerbation of chronic ulcerative colitis with mesalamine | Q72281905 | ||
| Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis | Q72307146 | ||
| Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease | Q72437063 | ||
| Paradoxical response to heparin in 10 patients with ulcerative colitis | Q72524292 | ||
| Transdermal nicotine as maintenance therapy for ulcerative colitis | Q72619156 | ||
| Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease | Q72677552 | ||
| Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis | Q72688420 | ||
| Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease | Q72848497 | ||
| Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study | Q73385241 | ||
| High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy | Q73386825 | ||
| Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis | Q73719439 | ||
| Cyclosporin for severe ulcerative colitis: a user's guide | Q73747657 | ||
| Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis | Q73837821 | ||
| Acute pancreatitis after long-term 5-aminosalicylic acid therapy | Q73943261 | ||
| Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis | Q73978420 | ||
| Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group | Q74036129 | ||
| Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease | Q74128877 | ||
| The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study | Q74315857 | ||
| Infliximab for refractory ulcerative colitis | Q74400737 | ||
| PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION | Q77108352 | ||
| Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study | Q77494204 | ||
| Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis | Q78371964 | ||
| Sulphasalazine and salicylazosulphadimidine in ulcerative colitis | Q79341873 | ||
| The treatment of chronic ulcerative colitis with 6-mercaptopurine | Q79587975 | ||
| Novel therapies in the treatment of ulcerative colitis | Q94178685 | ||
| Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial | Q34510060 | ||
| Reversible male infertility due to sulphasalazine: studies in man and rat | Q34526210 | ||
| Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis | Q34528243 | ||
| Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis | Q34530929 | ||
| Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study | Q34532266 | ||
| Corticosteroids in Crohn's disease | Q34633102 | ||
| Non-smoking: a feature of ulcerative colitis | Q34750283 | ||
| Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine | Q34755513 | ||
| Controlled trial of azathioprine in chronic ulcerative colitis | Q34759169 | ||
| Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine | Q34764697 | ||
| Steroid complications in patients with ulcerative colitis | Q35373905 | ||
| Randomised controlled trial of azathioprine withdrawal in ulcerative colitis | Q35822294 | ||
| A pharmacogenetic basis for the safe and effective use of azathioprine and other thiopurine drugs in dermatologic patients | Q39111522 | ||
| National Cooperative Crohn's Disease Study: adverse reactions to study drugs | Q39263882 | ||
| A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis | Q39453095 | ||
| An experiment to determine the active therapeutic moiety of sulphasalazine | Q39458926 | ||
| A Controlled Evaluation of Intravenous Adrenocorticotropic Hormone and Hydrocortisone in the Treatment of Acute Colitis | Q39942865 | ||
| Sulfasalazine. Adverse effects and desensitization | Q40091015 | ||
| A Controlled Comparison of Corticotropin and Hydrocortisone in the Treatment of Severe Proctocolitis | Q40131807 | ||
| Changes in extent of ulcerative colitis: a study on the course and prognostic factors | Q40671198 | ||
| Nicotine enemas for active ulcerative colitis--a pilot study | Q40879021 | ||
| A Comparison of Oral Prednisolone Given as Single or Multiple Daily Doses for Active Proctocolitis | Q40972287 | ||
| Mesalamine-induced lung toxicity | Q40988217 | ||
| Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France | Q41275908 | ||
| Intravenous cyclosporin in ulcerative colitis: a five-year experience | Q41671378 | ||
| A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis | Q41735945 | ||
| The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients | Q41839631 | ||
| CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS. | Q42115179 | ||
| Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis | Q42172189 | ||
| 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity | Q42255552 | ||
| Chronic interstitial nephritis and mesalazine: 3 new cases? | Q42538161 | ||
| Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study | Q42547552 | ||
| Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. | Q42668130 | ||
| Mesalazine (5-aminosalicylic acid) induced chronic hepatitis | Q43086987 | ||
| A double blind controlled trial of prednisolone-21-phosphate suppositories in the treatment of idiopathic proctitis | Q43250874 | ||
| Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. | Q43328678 | ||
| Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial | Q43363077 | ||
| Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis | Q43560942 | ||
| Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis | Q43582796 | ||
| Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis | Q43652424 | ||
| Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis | Q43679139 | ||
| Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease | Q43689444 | ||
| A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis | Q43719249 | ||
| Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine | Q43847764 | ||
| Double-blind comparison of olsalazine and sulphasalazine in active ulcerative colitis | Q44023626 | ||
| A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis | Q44048310 | ||
| Low-dose oral methotrexate in refractory inflammatory bowel disease | Q44068504 | ||
| Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis | Q44069781 | ||
| Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission | Q44148236 | ||
| Oral cyclosporine in patients with active severe ulcerative colitis not responding to steroids | Q44183574 | ||
| Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis | Q44230091 | ||
| Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications | Q44247087 | ||
| Response of refractory colitis to intravenous or oral tacrolimus (FK506). | Q44247090 | ||
| Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis | Q44255881 | ||
| Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column | Q44304714 | ||
| Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease | Q44446912 | ||
| Rescue therapy with tacrolimus in a patient with toxic megacolon. | Q44464856 | ||
| Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis | Q44988923 | ||
| Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease | Q44999341 | ||
| 5-Aminosalicylic acid suppositories in the maintenance of remission in idiopathic proctitis or proctosigmoiditis: a double-blind placebo-controlled clinical trial. | Q45204650 | ||
| A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis | Q45713741 | ||
| Intravenous azathioprine in severe ulcerative colitis: a pilot study. | Q45942088 | ||
| Transdermal nicotine for active ulcerative colitis | Q48848039 | ||
| A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. | Q50968026 | ||
| Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. | Q52443045 | ||
| Oral tobramycin in ulcerative colitis: effect on maintenance of remission. | Q52873006 | ||
| The role of azathioprine in the management of ulcerative colitis. | Q52875733 | ||
| Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. | Q53941725 | ||
| Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. | Q54007642 | ||
| Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease. | Q54023941 | ||
| Tacrolimus in corticosteroid-resistant ulcerative colitis. | Q54039583 | ||
| Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases. | Q54131635 | ||
| Azathioprine therapy in chronic ulcerative colitis. | Q54322297 | ||
| Intensive intravenous regimen for severe attacks of ulcerative colitis. | Q54394687 | ||
| Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. | Q55033133 | ||
| Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. | Q55036605 | ||
| Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone. | Q55228737 | ||
| Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. | Q55266577 | ||
| P433 | issue | 1 | |
| P921 | main subject | ulcerative colitis | Q1477 |
| P304 | page(s) | 7-19 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Clinics in colon and rectal surgery | Q26841890 |
| P1476 | title | Medical treatment of ulcerative colitis | |
| P478 | volume | 17 |
| Q38886949 | A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis |
| Q92446581 | A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis |
| Q35875340 | A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies |
| Q47865901 | Development of the rectal dosage form with silver-coated glass beads for local-action applications in lower sections of the gastrointestinal tract |
| Q49775886 | Early Outcome of Patient with Ulcerative Colitis who Received High Dose of Steroid and Underwent Two Staged Total Proctocolectomy. |
| Q26773203 | Optimal management of steroid-dependent ulcerative colitis |
| Q57812992 | Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease |
| Q35100726 | Pros and cons of medical management of ulcerative colitis |
| Q90136824 | Solitary rectal ulcer syndrome: addition of rectal therapies to biofeedback is more effective than biofeedback alone |
| Q37156469 | Specific immunotherapy ameliorates ulcerative colitis |
| Q42795386 | Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy |
Search more.